Mkts

Atara Biotherapeutics, Inc.

NASDAQ: ATRA
$7.87-0.09 (-1.13%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
7.748.00
52-week range
3.9219.14
Today
Open7.86
Previous close7.87
Volume29.5K
Valuation
Market cap79.90M
P/E ratio—
EPS (TTM)-1.18
Income & risk
Dividend / yield—
Beta0.35
Avg volume48.7K
Discussion

ATRA News

Stories mentioning ATRA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue516.001,5953,45317,57598,14932,75340,19028,640
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development164.00(223.00)2,9257,31027,43328,72143,92433,332
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(3,369)(2,563)(3,574)3,19738,802(12,203)(21,757)(18,231)
Interest Income
Interest Expense830.00894.00909.00972.001,0171,0171,1831,262
Other Expense0.00(49.00)4.0022.00(11.00)(89.00)555.00(6.00)
Pretax Income(4,145)(3,406)(4,275)2,39038,010(12,712)(21,926)(19,049)
Tax Provision0.000.0028.003.000.00(19.00)(17.00)0.00
Net Income (Loss)(4,145)(3,406)(4,303)2,38738,010(12,693)(21,909)(19,049)
Earnings Per Share (Basic)(0.29)(0.27)(0.32)0.203.53(1.70)(2.93)(3.10)
Earnings Per Share (Diluted)(0.29)(0.27)(0.32)0.193.50(1.70)(2.93)(3.10)
Weighted Average Shares Outstanding (Basic)14,08112,54413,56412,19710,7647,4887,4666,143
Weighted Average Shares Outstanding (Diluted)14,08112,71813,56412,31010,8517,4887,4666,143

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ATRA

Atara Biotherapeutics, Inc. (NASDAQ: ATRA) is a stock listed on the Nasdaq Stock Market under the ticker symbol ATRA. It last traded at $7.87 (Nov 6, 2026, 4:00 PM ET), down 1.1% on the day. That gives Atara Biotherapeutics a market capitalisation of $79.9M.

Over the past 52 weeks ATRA has traded between $3.92 and $19.14.

Revenue for the quarter ended Mar 31, 2026 was $516.0K; a net loss of $4.1M. Revenue was down 99.5% from $98.1M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$516.0K-$4.1M-803.3%
Dec 31, 2025$1.6M-$3.4M-213.5%
Sep 30, 2025$3.5M-$4.3M-124.6%
Jun 30, 2025$17.6M$2.4M13.6%

From Atara Biotherapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…